Skip to content
LongevityGraded

Review

Care Bare Rx Review: The NAD+ Price on the Site Is Not a Price

Care Bare Rx NAD+ costs $325 a month in its own catalog, not the "$199" its pages advertise. No prepay term; an $80 fee applies if nothing is prescribed.

Researched & graded by · Lead Reviews Analyst
Last graded
On this page
B

Featured partner

Grade B

CoreAge Rx

Clinician-reviewed NAD+ and sermorelin with published starting prices and human support. Confirm the full cost and renewal terms before paying.

$93–$99/mo (starting rates)

We may earn a commission through this link, at no extra cost to you.

Check availability
Pricing
Varies by plan
Pharmacy
503A compounding pharmacy
Labs
Depends on treatment
Consult
Clinician review included
Support
Human support included

Grades come from each provider's published terms. How we're funded

B

Partner

Grade B

Strut Health

The cheapest published month-to-month sermorelin here, with the visit and follow-up care genuinely inside it.

$99–$119/mo

We may earn a commission through this link, at no extra cost to you.

Visit Strut Health

Regulatory record: FDA warning letter · February 2026 — see our full Strut Health review.

The headline requires auto-refill; the one-off price is 18% higher and is not published anywhere on the site. Compounded and not FDA-approved. Graded on the same rubric as every other provider on our scorecard.

The one-sentence version

Care Bare Rx publishes more about who prescribes and who dispenses than almost anything else here — four pharmacies with street addresses and phone numbers, four clinicians with NPI numbers you can look up — and then advertises an NAD+ price that matches nothing in its own catalog. The site says "NAD+ Treatments Starting at $199", directly beneath the words "Transparent pricing". Its catalog holds exactly one NAD+ product, at $325 a month. It grades B, 9 points out of 14, computed from its published terms alone.

What it is, and who it's for

Care Bare Rx is a telehealth brand positioned around LGBTQ+ care — "a wellness brand designed for those who want their health routine to feel as good as it looks" — running on CareGLP by CareValidate, with its own online intake and Stripe at checkout. The backend organization is CareBareHealth.

The line this site ranks is three products: NAD+ injection (200 mg/mL, 10 mL), sermorelin acetate injection (2 mg/mL, 10 mL) and B-12 methylcobalamin (5 mg/mL). Beside them sit compounded semaglutide and tirzepatide with dose-tiered pricing, brand-name GLP-1s, a hair line and a sexual-health line. There is no glutathione, no other growth-hormone peptide, no methylene blue, no TRT or HRT and no supplements.

Note the dose tiering, because it is a real point in Care Bare's favor and its sibling brands do not do it: compounded semaglutide is $199 at 0.25 mg, $249 at 0.5 and 1 mg, $299 at 1.5 and 2 mg, and tirzepatide $299 / $349 / $399 across its three bands. A buyer can see what titrating up will cost before starting. Synergy Rx, on the same platform, strips that ladder out entirely.

The price problem, in three parts

Advertised, and charged

NAD+ injection"Starting at $199"$325/mo — the only NAD+ product
Sermorelin injectionNo price advertised$300/mo
B-12 methylcobalaminNo price advertised$200/mo
Ozempic® (landing page)$749$705
Hair line (landing page)$99$180
Sexual health (landing page)$99$120
From Care Bare Rx's marketing pages and its own catalog. The left column is what the site advertises; the right is what the checkout sells.

1. The advertised NAD+ figure is purchasable at no tier. Every marketing page carries "NAD+ Treatments Starting at $199", and on the homepage that line sits in a block whose own bullet points include "Transparent pricing, discreet delivery, real results." The catalog behind Care Bare's own intake has one NAD+ product. It costs $325. There is no $199 tier, no $199 dose, no $199 promotional rung. The number is not a prepay rate that turns out to need twelve months, and not an intro month that steps up at the first refill. Those at least correspond to something somebody pays. This one corresponds to nothing.

2. One of its own landing pages advertises a third set of numbers. Care Bare runs a marketing landing page that shows Ozempic at $749, hair at $99 and sexual health at $99. Its About and FAQ pages show $705, $180 and $120 — and the checkout catalog agrees with those. So a reader arriving from an ad can land on the page whose figures are wrong, and find the corrected ones only by navigating away from it.

3. The bundles are labeled in the wrong unit. On its GLP-1 page, "Semaglutide 3-Month Bundle From $748/mo" is a three-month total — $249 a month — and "Tirzepatide 3-Month Bundle From $1068/mo" is $356 a month. The "/mo" is on a figure that is not monthly.

What that costs, and why. Our rubric asks for one all-in figure, visible before you commit, that a buyer with no commitment actually pays. Care Bare has such a figure — $325, month-to-month, no prepay term — but it is not on any page a shopper reads, and the figure that is on those pages is off by 63%. Price transparency scores zero, and it is the same call Telos Rx gets for advertising its longest plan's rate as though it were monthly. Compare Sprout Health, whose $199 headline is a genuine first-month rate with the $249 standing rate published beside it, and which keeps all four points. The difference is not honesty of intent — it is whether the number on the page is a number somebody is charged.

And two costs that are not in any headline. An $80 telehealth consult fee applies "if medication isn't prescribed" — stated in the catalog's own fineprint rather than on the marketing pages. And the Terms make medical consult fees non-refundable and state that all sales are final.

What Care Bare publishes that most providers here do not

Four dispensing pharmacies, named, with street addresses and phone numbers, on its own FAQ:

  • Belmar Pharmacy — 6597 N 92nd St, Suite 105, Scottsdale, AZ 85260 · 800.525.9473
  • Strive Pharmacy — 21143 Hawthorne Blvd, Suite 305, Torrance, CA 90503 · 855.405.5993
  • Epiq Scripts — 625 Herndon Ave, Suite D, Clovis, CA 93612 · 833.654.3553
  • Casa Pharma Rx — 12855 Capricorn St, Stafford, TX 77477 · 877.937.6868

What it does not do is classify them. The only mention of the statute on that page is a general compliance list — "State boards of pharmacy, which regulate all 503A pharmacies" — which is an explanation of who regulates whom, not a statement that your prescription is filled under 503A. Our published methodology draws that line deliberately, so Care Bare takes the middle rung: one point of two, for naming without classifying.

Four clinicians, named, with NPI numbers. The clinical group is Lion MD: Dr. Ana Lisa Carr, MD (NPI 1689841744) and Dr. Kelly Tenbrink, MD (NPI 1346482684) leading, with Dr. HirenKimar Italia, MD (NPI 1487815387) and Dr. David Mansour, DO (NPI 1689164949) as supporting medical team. Four checkable identifiers is more than any other provider on this site publishes.

Belmar, and the thing to know in proportion. One of those four pharmacies, Belmar, received an FDA warning letter issued 31 March 2023, addressed to "Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy" — and FDA closed it out on 30 October 2023. We do not restate what it alleged; that is FDA's document to characterize, and the searchable index is linked below1. Two things matter. The letter is closed out, and any page that leaves that off is publishing a false impression. And you only know about it because Care Bare names its pharmacies: the providers here that name nobody could be dispensing through anyone, and there would be nothing for you to check. Care Bare Rx itself holds no FDA warning letter in FDA's public index.

Support and oversight are inside the price. The homepage's own three-step explainer ends with "Ongoing Support & Delivery — We ship your meds directly to you with follow-up care and optional coaching." Follow-up care stated as part of the program is what our support factor asks for; the coaching is hedged as optional and is not what the point is given for. And because the only consult charge published is the $80 that applies when nothing is prescribed, the clinician review sits inside the medication price for anyone who is prescribed.

The states question, and its answer

Care Bare's FAQ says: "We provide service to all 50 states and Puerto Rico."

Its own catalog copy says something else. B-12 carries a no-ship list — Alabama, Arkansas, Alaska, Connecticut, Indiana, Kentucky, Louisiana, Michigan, Minnesota, Vermont and Wisconsin — and NAD+ in those same eleven states "will be supplied by secondary pharmacies. Cost may vary."

Both sentences are live. The reconciliation is that the GLP-1 line may well be fifty-state while the wellness line is not, and that the NAD+ price is not fixed everywhere even where the product is available. If you live in one of the eleven, get your own number in writing before paying.

Two smaller things in the same register: the homepage testimonials are recycled from CareGLP, the white-label platform behind the brand — one of them praises "what I expected from CareGLP" rather than Care Bare — and Mounjaro is flagged sold out in the catalog while still being advertised on the marketing pages.

The evidence behind what it sells

This ranking grades providers, not molecules, and Care Bare markets within the category's normal register. But NAD+ at $325 a month is $3,900 a year, so the evidence belongs in the decision.

NAD+ precursors reliably raise NAD+ levels in the blood, but better energy, strength or health in healthy adults has not followed, and injected NAD+, the route Care Bare sells, has the least human outcome evidence of all. The details are in NAD+ injections vs IV vs oral.

Sermorelin raises your own growth hormone, and raising growth hormone in healthy older adults has not been shown to improve how they function, while side effects go up. See sermorelin for longevity. Compounded NAD+ and sermorelin are not FDA-approved, and FDA's own position is that compounded drugs are not FDA-approved and it does not verify their safety, effectiveness or quality before marketing2. Read what the NAD+ evidence actually supports before deciding a year of this is worth it.

Before you start

Five things to settle before you pay Care Bare Rx

  • Budget $325 a month for NAD+, not the $199 advertised site-wide. The catalog holds one NAD+ product and that is its price.
  • Ignore the landing page's figures. Ozempic $749, hair $99 and sexual health $99 there; $705, $180 and $120 in the checkout.
  • Check the eleven-state exception. B-12 is not shipped to AL, AR, AK, CT, IN, KY, LA, MI, MN, VT or WI, and NAD+ there comes from secondary pharmacies where "cost may vary".
  • Budget the $80 consult fee if nothing is prescribed — and note the Terms make consult fees non-refundable and all sales final.
  • Read the bundle labels. "Semaglutide 3-Month Bundle From $748/mo" is a $748 three-month total, or $249 a month.

Where it's weak, and who should skip it

Skip it if you budget from the advertised number, because the advertised number is not the number — plan for $325 a month for NAD+, not $199. Skip it if you arrive on its marketing landing page and want to buy what it shows you, because its Ozempic, hair and sexual-health figures are not the ones the checkout charges. Skip it if you live in one of the eleven no-ship states and need a fixed NAD+ price, because Care Bare says explicitly that yours may vary. And skip it if a non-refundable consult fee and an all-sales-final policy are risks you will not take.

Buy it if the disclosure is what you are actually shopping for and you are prepared to confirm the price yourself. Four named pharmacies with addresses, four named clinicians with NPI numbers, a published dose ladder on the GLP-1 line, month-to-month with no prepay term and follow-up care inside the price is a genuinely strong package — attached to marketing copy that has not been reconciled with the catalog behind it.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). Care Bare takes the full four for its longevity line — NAD+, sermorelin and B-12 are what this site ranks — two for clinical oversight, because the consult is inside the medication price unless nothing is prescribed, two for support, on published follow-up care, and one of two for pharmacy, for naming four facilities without classifying any. It takes zero for price transparency, because the figure it advertises for the product this site grades is purchasable at no tier. Nine out of fourteen: a B.

The fix is a single line of copy. Change "Starting at $199" to "$325 a month" and Care Bare moves to thirteen and an A without touching the medicine, the pharmacies, the clinicians or the price itself. That is worth stating plainly, because it locates the problem exactly: this is not a company hiding what it charges — it is a company advertising a number its own system cannot sell you. The full graded field is at our provider rankings, and what this category costs generally is in longevity clinic cost.

Compare Care Bare Rx with

We may earn a commission through these links, at no extra cost to you. Disclosure

A

Partner

Oak $175/mo NAD+ (reg. $199)

Visit Oak

See every graded provider ↗

Frequently asked questions

How much does Care Bare Rx NAD+ cost?

$325 a month, month-to-month, in Care Bare's own catalog. That is the only NAD+ product it sells: a 200 mg/mL, 10 mL injection. Sermorelin acetate injection is $300 a month and B-12 methylcobalamin is $200. The reason this question needs answering carefully is that every marketing page on Care Bare's site advertises "NAD+ Treatments Starting at $199", and no tier at that price exists anywhere in the catalog. It is not a first-month rate that steps up and not a prepay rung that needs twelve months; it corresponds to nothing you can buy. Budget $325. One further caveat: in the eleven states Care Bare's own copy lists as no-ship for B-12, NAD+ is supplied by secondary pharmacies where "cost may vary", so confirm your own figure before paying.

Why is the price on Care Bare's landing page different from the price at checkout?

Because the landing page has not been reconciled with the catalog. Care Bare runs a marketing landing page that advertises Ozempic at $749, the hair line at $99 and the sexual-health line at $99. Its About page and FAQ show $705, $180 and $120, and the checkout catalog agrees with those. So a reader arriving from an ad can see the wrong set and find the right one only by navigating away. The practical rule is simple: treat any figure on that landing page as marketing rather than price, and confirm the number on the About page, the FAQ or at checkout before you enter a card.

Which pharmacies and clinicians does Care Bare Rx use?

It names both, which most providers here do not. Its own FAQ lists four dispensing pharmacies with street addresses and phone numbers: Belmar Pharmacy (6597 N 92nd St, Suite 105, Scottsdale, AZ 85260, 800.525.9473), Strive Pharmacy (21143 Hawthorne Blvd, Suite 305, Torrance, CA 90503, 855.405.5993), Epiq Scripts (625 Herndon Ave, Suite D, Clovis, CA 93612, 833.654.3553) and Casa Pharma Rx (12855 Capricorn St, Stafford, TX 77477, 877.937.6868). The clinical group is Lion MD, and four physicians are named with NPI numbers you can verify yourself: Dr. Ana Lisa Carr, MD (1689841744), Dr. Kelly Tenbrink, MD (1346482684), Dr. HirenKimar Italia, MD (1487815387) and Dr. David Mansour, DO (1689164949). What Care Bare does not do is classify the pharmacies — the only mention of the statute on that page is a general note that state boards regulate 503A pharmacies, which is an explanation of the regulatory landscape rather than a claim about who fills your prescription. So you know who compounds your medication, but not under which regime.

One of Care Bare's pharmacies had an FDA warning letter — does that matter?

It matters as a disclosure, not as a disqualification, and the closure date is the part most write-ups leave off. Belmar — one of the four pharmacies Care Bare names — received an FDA warning letter issued 31 March 2023, addressed to "Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy". FDA closed it out on 30 October 2023. We do not restate the allegations; that is FDA's document to characterize, and the searchable index is cited on this page so you can read it yourself. Two things are worth holding onto. The letter is closed out, so a page describing it as an open action is publishing a false impression. And you only know about it because Care Bare names its pharmacies at all — the providers here that name none could be dispensing through anyone. Care Bare Rx itself holds no FDA warning letter in FDA's public index.

Does Care Bare Rx really serve all 50 states?

Its FAQ says "We provide service to all 50 states and Puerto Rico." Its own catalog copy contradicts that for the wellness line. B-12 methylcobalamin carries a no-ship list of Alabama, Arkansas, Alaska, Connecticut, Indiana, Kentucky, Louisiana, Michigan, Minnesota, Vermont and Wisconsin, and NAD+ in those same eleven states "will be supplied by secondary pharmacies. Cost may vary." Both statements are live on the site today. The most likely reconciliation is that the GLP-1 line is genuinely nationwide while the injectable wellness line is not, and that even where NAD+ is available in those eleven states the published price is not fixed. If you live in one of them, get your own state confirmed and your own figure quoted in writing before you pay anything.

Why does Care Bare Rx grade B rather than A?

It loses four of its five missing points in one place. Price transparency, which our rubric weights double, scores zero: the factor asks for a figure a buyer can rely on before committing, and the figure Care Bare puts on every marketing page for the product this site grades — "NAD+ Treatments Starting at $199" — is purchasable at no tier in its own catalog, where the single NAD+ product costs $325. It also drops one of two pharmacy points, for naming four dispensing facilities without classifying any of them as 503A or 503B. Everything else scores full marks: four for a genuine longevity line, since NAD+, sermorelin and B-12 are exactly what this site ranks; two for clinical oversight, since the consult sits inside the medication price and the only consult charge published is the $80 that applies when nothing is prescribed; and two for support, on published follow-up care. That is 9 out of 14, a B. Changing one line of marketing copy from $199 to $325 would make it 13 and an A without altering the medicine, the pharmacies, the clinicians or the price.

References

  1. U.S. Food and Drug Administration (2026). Warning Letters (searchable index of FDA warning letters, with issue and close-out dates). FDA — Compliance Actions and Activities.
  2. U.S. Food and Drug Administration (2025). Compounding and the FDA: Questions and Answers ('Compounded drugs are not FDA-approved'; 503A pharmacies are not subject to CGMP requirements). FDA — Human Drug Compounding.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.